HEALTH. The wait hopes to successfully develop the vaccine / EFE
This Thursday, Moderna reported that it is in the process of developing a vaccine that serves both as a booster against the COVID-19 pandemic and to attack influenza, a dose the latter a common dose that is applied in the United States as winter approaches.
Because it is important?: The pharmaceutical company hopes to materialize a project with which it would face two problems under the same injection. At the moment, the company has several doses among its candidates to apply against influenza in the coming months.
- According to the Reuters news agency, it would combine the most advanced version of its vaccine against the pandemic.
- The company added that it is developing a vaccine for respiratory syncytial virus.
What do they say?: “We believe this is just the beginning of a new era of information-based medicines,” Moderna CEO Stéphane Bancel said in a press release.
- “Today we announce the first step in our innovative respiratory vaccine program with the development of a single-dose vaccine,” he added.
- Moderna joins Novavax as the companies whose goal is to combine vaccines.
Main source of the news: Modern